Abbonarsi

Current hyperkalemia interventions co-administered with a dextrose 10% solution significantly lower hypoglycemic rates (CHICA-D10) - 10/09/24

Doi : 10.1016/j.ajem.2024.07.061 
Francisco Ibarra, PharmD, BCCCP a, b, c, , Cade Fountain b , Tyler Fallert a
a Community Regional Medical Center, Department of Pharmacy Services, P.O. Box 1232, Fresno, CA 93715, United States of America 
b California Health Sciences University (CHSU), College of Osteopathic Medicine, 2500 Alluvial Ave, Clovis, CA 93611, United States of America 
c University of California San Francisco at Fresno, Department of Emergency Medicine, 155 N Fresno St, Fresno, CA 93701, United States of America 

Corresponding author at: Community Regional Medical Center, Department of Pharmacy Services, P.O. Box 1232, Fresno, CA 93715, United States of America.Community Regional Medical CenterDepartment of Pharmacy ServicesP.O. Box 1232FresnoCA93715United States of America

Abstract

Background

Current protocols which include the administration of a single dextrose dose concomitantly with insulin are inadequate as hypoglycemia commonly occurs 60 min after insulin administration and may persist for up to two hours post-insulin administration. To prevent delayed hypoglycemic events, our institution revised our adult acute hyperkalemia order set to include hypoglycemic preventative measures not currently described in the literature.

Methods

The primary purpose of this retrospective study was to determine if the new adult acute hyperkalemia order set resulted in lower rates of hypoglycemia (glucose <70 mg/dL) compared to the old order set in patients with impaired renal clearance and lower pre-insulin glucose values. In addition to reducing the IV regular insulin dose from 10 to 5 units, the new order set recommends patients receive a 250 mL dextrose 10% solution over two hours in addition to a 50 mL dextrose 50% IV push concomitantly with IV regular insulin if their pre-insulin glucose is ≤250 mg/dL. Patients were included if they were adults, received IV regular insulin from the order set within six hours of presenting to the ED, had a pre-insulin potassium >5.5 mmol/L, had a pre-insulin glucose ≤250 mg/dL, and had impaired renal clearance [creatinine clearance (CrCl) < 30 mL/min or dialysis dependent].

Results

100 patients were included in each arm. The median pre-insulin potassium levels were 6.4 mmol/L and 6.3 mmol/L in the old and new groups, respectively (p = 0.133). The median pre-insulin glucose levels were 120 mg/dL and 107.5 mg/dL in the old and new groups, respectively (p = 0.013). Twenty (20%) patients in the old group developed hypoglycemia, whereas six (6%) patients in the new group developed hypoglycemia (p = 0.003). There was no significant difference between the two groups in number of patients who achieved a post-insulin potassium level ≤ 5.5 mmol/L.

Conclusion

Our study found that our approach of additionally administering a 250 mL dextrose 10% solution upon therapy initiation is associated with significantly lower rates of hypoglycemia. Our findings indicate that hypoglycemia rates can be significantly reduced in vulnerable populations if additional preventative measures are employed.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Hyperkalemia, Hypoglycemia, Renal failure, Potassium, Insulin


Mappa


© 2024  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 84

P. 120-123 - ottobre 2024 Ritorno al numero
Articolo precedente Articolo precedente
  • A dynamic online nomogram predicting post-traumatic arrhythmias: A retrospective cohort study
  • Jianmei Long, Xiaohui Liu, Shasha Li, Cui Yang, Li Li, Tianxi Zhang, Rujun Hu
| Articolo seguente Articolo seguente
  • The impact of recreational cannabis legalization on ED visit rates for acute cannabis intoxication
  • An Nguyen, Ray Lee, Lili Zhao, Lihua Qu, Brett Todd

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.